Navigation Links
The Johns Hopkins Center for Inherited Disease Research receives $101 million
Date:8/10/2012

The Johns Hopkins Center for Inherited Disease Research (CIDR) program contract, which provides up to $101 million in research funding from the National Institutes of Health (NIH) to study the genetic contribution to human diseases, has been renewed for another five years.

"We are thrilled the NIH has awarded us this contract," says Kimberly Doheny, Ph.D., lead principal investigator of CIDR. "The bulk of the contract support allows us to generate sequencing or genotyping datasets for an average of 30 large genetic studies per year. A separate component of the contract supports the center's infrastructure, including the exploration of new technologies and the extensive IT infrastructure necessary to serve new data-intensive methods, like high-throughput genomic technologies."

CIDR, part of the McKusick-Nathans Institute of Genetic Medicine at Johns Hopkins, is a national resource for genetics researchers. Established in 1996, the center performs DNA genotyping and sequencing to identify genes linked to disease. CIDR also offers statistical genetics consultation to investigators. Researchers at CIDR thus far have analyzed over 620,000 DNA samples and identified genes associated with cancer, addiction, glaucoma, Parkinson's disease and many other genetic diseases.

Doheny, along with David Valle, M.D., Henry J. Knott Professor and director of the Institute of Genetic Medicine, and Alan Scott, Ph.D., will serve as the co-principal investigators of the center.

"CIDR's main goal is to support the genetics community a large group of molecular geneticists and bioinformaticians in their efforts to find genes that contribute to disease," says Valle. "We share our expertise with the Johns Hopkins community and offer fee-for-service access to our facility to all investigators."

The NIH program contract was initially awarded to CIDR in 1996 by the NIH and renewed in 2007 and now again in 2012. The contract receives funding from 14 NIH institutes. Investigators with grants from one of these institutes can apply for access to CIDR's sequencing and genotyping services. If the project is approved, the supporting NIH institute pays for the project directly through the contract. Access to the CIDR resources is also available on a fee-for-use basis through the Johns Hopkins Genetic Resources Core Facility (grcf.jhmi.edu).


'/>"/>

Contact: Vanessa McMains
vmcmain1@jhmi.edu
410-502-9410
Johns Hopkins Medicine
Source:Eurekalert

Related biology news :

1. Johns Hopkins researchers uncover genes at fault for cystic fibrosis-related intestinal obstruction
2. Johns Hopkins researchers link 2 biological risk factors for schizophrenia
3. New Center for Carbon Measurement to drive UKs low carbon economy
4. Israel names Tel Aviv Universitys Renewable Energy Center a Center of Research Excellence
5. Heart study suggests city center pollution doubles risk of calcium build-up in arteries
6. Mainz University Medical Center attracts funding of Alexander von Humboldt Professorship
7. UC Santa Cruz builds national data center for cancer genome research
8. UF to establish Faroe Island research center with help of baseball star
9. DOE Plasma Science Center Annual Meeting at Princeton Plasma Lab
10. UH Case Medical Center, CardioKinetix reveal promising data for treatment for heart failure
11. Tufts Medical Center researchers finds marker in premies saliva predicts readiness to feed by mouth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... patient care by providing unparalleled technology to leaders of the medical imaging industry.  As ... added to the range of products distributed by Ampronix. Photo - ... ... ... ...
(Date:5/16/2016)... 16, 2016   EyeLock LLC , a market ... opening of an IoT Center of Excellence in ... the development of embedded iris biometric applications. ... convenience and security with unmatched biometric accuracy, making it ... from DNA. EyeLock,s platform uses video technology to deliver ...
(Date:5/9/2016)... May 9, 2016 Elevay is ... to expanding freedom for high net worth professionals seeking ... today,s globally connected world, there is still no substitute ... ever duplicate sealing your deal with a firm handshake. ... by taking advantage of citizenship via investment programs like ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers use ... 6000i models are higher end machines that use the more unconventional z-dimension of 20mm. ... from the bottom of the cuvette holder. , FireflySci has developed several Agilent ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... NEW YORK , June, 23, 2016  The ... students to envision new ways to harness living systems ... of Modern Art (MoMA) in New York ... more than 130 participating students, showcased projects at MoMA,s ... included Paola Antonelli , MoMA,s senior curator of ...
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
Breaking Biology Technology: